Literature DB >> 36027629

Challenging clinical scenarios for therapeutic anticoagulation: A practical approach.

Kylee L Martens1, Simone E Dekker2, Megan Crowe2, Thomas G DeLoughery3, Joseph J Shatzel3.   

Abstract

Therapeutic anticoagulation remains a fundamental backbone in the treatment and prevention of venous thromboembolism. However, while modern therapies are increasingly safe, anticoagulation is not without risks, particularly in those at high risk for or with recent bleeding. When weighing concurrent risks and benefits in each challenging clinical scenario, an individualized assessment of the risk and acuity of bleeding should be balanced by the indication for anticoagulation. Addressing modifiable risk factors and routine re-evaluation of any changes in this balance is critical. This review outlines available data and current guidelines for the management of anticoagulation in high-risk populations, including those with thrombocytopenia, elderly and high-fall risk, inherited bleeding disorders, and in acute coronary syndrome. We also examine management after clinically significant bleeding episodes, including intracranial hemorrhage, gastrointestinal bleeding, hemoptysis, retroperitoneal bleeding, hematuria, and abnormal uterine bleeding. The aim is to provide a comprehensive review of available literature to guide clinicians in providing optimal, safe, and individualized care for patients in these challenging scenarios.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anticoagulation management; Thrombosis and hemostasis

Mesh:

Substances:

Year:  2022        PMID: 36027629      PMCID: PMC9481720          DOI: 10.1016/j.thromres.2022.08.015

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   10.407


  97 in total

1.  British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE.

Authors:  I A Du Rand; J Blaikley; R Booton; N Chaudhuri; V Gupta; S Khalid; S Mandal; J Martin; J Mills; N Navani; N M Rahman; J M Wrightson; M Munavvar
Journal:  Thorax       Date:  2013-08       Impact factor: 9.139

Review 2.  Treatment of bleeding complications in patients on anticoagulant therapy.

Authors:  Siavash Piran; Sam Schulman
Journal:  Blood       Date:  2018-12-17       Impact factor: 22.113

3.  Spontaneous retroperitoneal hematoma: etiology, characteristics, management, and outcome.

Authors:  Kharmene L Sunga; M Fernanda Bellolio; Rachel M Gilmore; Daniel Cabrera
Journal:  J Emerg Med       Date:  2011-09-10       Impact factor: 1.484

Review 4.  Venous thromboembolism: Past, present and future.

Authors:  Sam Schulman; Walter Ageno; Stavros V Konstantinides
Journal:  Thromb Haemost       Date:  2017-06-08       Impact factor: 5.249

5.  Spontaneous rectus sheath hematomas: when to restart anticoagulation?

Authors:  Meghana R Kunkala; Jack Kehl; Martin D Zielinski
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

6.  Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.

Authors:  Christian T Ruff; Robert P Giugliano; Eugene Braunwald; Elaine B Hoffman; Naveen Deenadayalu; Michael D Ezekowitz; A John Camm; Jeffrey I Weitz; Basil S Lewis; Alexander Parkhomenko; Takeshi Yamashita; Elliott M Antman
Journal:  Lancet       Date:  2013-12-04       Impact factor: 79.321

7.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

Authors:  Clive Kearon; Elie A Akl; Joseph Ornelas; Allen Blaivas; David Jimenez; Henri Bounameaux; Menno Huisman; Christopher S King; Timothy A Morris; Namita Sood; Scott M Stevens; Janine R E Vintch; Philip Wells; Scott C Woller; Lisa Moores
Journal:  Chest       Date:  2016-01-07       Impact factor: 9.410

8.  A Multicenter Trial of Vena Cava Filters in Severely Injured Patients.

Authors:  Kwok M Ho; Sudhakar Rao; Stephen Honeybul; Rene Zellweger; Bradley Wibrow; Jeffrey Lipman; Anthony Holley; Alan Kop; Elizabeth Geelhoed; Tomas Corcoran; Philip Misur; Cyrus Edibam; Ross I Baker; Jenny Chamberlain; Claire Forsdyke; Frederick B Rogers
Journal:  N Engl J Med       Date:  2019-07-07       Impact factor: 91.245

9.  Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism.

Authors:  Jan Bĕlohlávek; Vladimír Dytrych; Aleš Linhart
Journal:  Exp Clin Cardiol       Date:  2013

10.  Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH.

Authors:  B T Samuelson Bannow; A Lee; A A Khorana; J I Zwicker; S Noble; C Ay; M Carrier
Journal:  J Thromb Haemost       Date:  2018-05-08       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.